Literature DB >> 17556070

Frequent chromosomal gains in recurrent juvenile nasopharyngeal angiofibroma.

Ulf-Rüdiger Heinrich1, Jürgen Brieger, Jan Gosepath, Magorzata Wierzbicka, Maxim Sokolov, Yehudah Roth, Witold Szyfter, Fernando Bittinger, Wolf J Mann.   

Abstract

Juvenile nasopharyngeal angiofibroma (JNA) is a rare benign tumor, mostly affecting adolescent males. Some patients develop recurrences after surgery independently of completeness of removal. Only very limited data concerning underlying chromosomal changes are available. We therefore analyzed samples of 22 JNAs, including six recurrences, with comparative genomic hybridization (CGH). Additionally, quantitative image cytometry was used for measurement of DNA aneuploidy in representative samples. Of the 13 primary JNAs without later recurrence, DNA gains were identified on autosomes in only two samples. Four patients with one or two recurrences were included in the study; for one of these, no material of the primary tumor was available for analysis. Looking at autosomes, two of the three available primaries displayed multiple gains; in one of those, two additional losses were observed. Multiple gains were detected in two of the four first recurrences, but none in the two second recurrences. Across all 22 samples, gains occurred in more than one sample on chromosomes arms 1p, 9q, 10q, 12q, 16p, 16q, 17q, 19p, 19q, 20q, and 22q. Losses were found in a single case exclusively on chromosome 4. Sex chromosomes were frequently affected in both primary tumors and recurrences. There was no correlation among tumor staging, age, and DNA amplification. No DNA aneuploidy was detected, a finding in accordance with the generally benign characteristics of JNAs. Our observations suggest that in JNA the activation of oncogenes is more likely than the inactivation of tumor suppressor genes. Autosomal gains in the primary tumor should be further evaluated as markers for a potentially increased risk of recurrence after surgical removal in this entity.

Entities:  

Mesh:

Year:  2007        PMID: 17556070     DOI: 10.1016/j.cancergencyto.2007.02.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Epstein-Barr virus and human herpes virus-8 are not associated with juvenile nasopharyngeal angiofibroma.

Authors:  Román Carlos; Lester D R Thompson; Ana Carolina Netto; Luiz Gustavo Garcia Santos Pimenta; Jeane de Fátima Correia-Silva; Carolina Cavaliéri Gomes; Ricardo Santiago Gomez
Journal:  Head Neck Pathol       Date:  2008-07-01

2.  Stridor: an unusual presentation of juvenile nasopharyngeal angiofibroma.

Authors:  Hitendra Prakash Singh; Sunil Kumar; Madhukar Vashishtha; Satya Prakash Agarwal
Journal:  BMJ Case Rep       Date:  2014-04-07

3.  Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis.

Authors:  Yuanji Xu; Xinyi Huang; Wangzhong Ye; Yangfan Zhang; Changkun Li; Penggang Bai; Zhizhong Lin; Chuanben Chen
Journal:  Cancer Cell Int       Date:  2020-08-26       Impact factor: 5.722

4.  Juvenile Nasopharyngeal Angiofibroma Extending into the Oral Cavity: A Rare Entity.

Authors:  Nilesh Pardhe; Neha Chhibber; Deshant Agarwal; Manish Jain; Pradkhshana Vijay
Journal:  J Clin Diagn Res       Date:  2015-06-01

5.  Juvenile angiofibroma: evolution of management.

Authors:  Piero Nicolai; Alberto Schreiber; Andrea Bolzoni Villaret
Journal:  Int J Pediatr       Date:  2011-11-17

6.  Neural Crest Stem Cells in Juvenile Angiofibromas.

Authors:  Bernhard Schick; Lukas Pillong; Gentiana Wenzel; Silke Wemmert
Journal:  Int J Mol Sci       Date:  2022-02-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.